FDA inspection
Aurobindo Pharma Limited: FDA inspection ending Dec 22, 2010
FDA inspection 711843 · Official Action Indicated (OAI) · Sangareddy
Key facts
| Inspection ID | 711843 |
|---|---|
| Firm | Aurobindo Pharma Limited |
| FEI number | 3004021263 |
| Address | Unit 6, 39 & 329 47 Survey No 329 |
| City | Sangareddy |
| Country | India |
| Fiscal year | 2011 |
| Inspection end date | Dec 22, 2010 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 180094 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data